STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
100 hedge funds and large institutions have $445M invested in Stemline Therapeutics, Inc. in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 56 increasing their positions, 18 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
69% less call options, than puts
Call options by funds: $292K | Put options by funds: $932K
Holders
100
Holding in Top 10
1
Calls
$292K
Puts
$932K
Top Buyers
| 1 | +$16.7M | |
| 2 | +$16.3M | |
| 3 | +$10.1M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$8.33M |
| 5 |
Alkeon Capital Management
New York
|
+$6.4M |
Top Sellers
| 1 | -$6.06M | |
| 2 | -$5.45M | |
| 3 | -$3.59M | |
| 4 |
FI
Fosun International
Hong Kong,
China
|
-$3.21M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.14M |